The Presidential Task Force (PTF) on COVID-19 has announced that it will allow clinicians to add dexamethasone, the life-saving drug recently discovered by a team of researchers from the United Kingdom, to their treatment regimen for trial.
The Minister of Health, Dr Osagie Ehanire who made the announcement during the daily briefing of the Presidential Task Force on COVID-19 on Thursday, June 18, said dexamethasone is not a “drug you should be using but a medicine that the doctor is to use.”
“I did mention that there is a medicine that we are going to ask our clinicians to try. It is not a medicine that you should be using but medicine that the doctor is to use.
“Luckily this medicine is not new and it is well-known to be used for other purposes as a steroid. It was found to be useful in this case. It is easy to try it out because we know the side effects. Also, the usual dosage is well-known and it is not a medicine that is terribly expensive or unavailable.
“We are going to ask our clinicians to also consider adding it for their trials and see what results from it works in our own circumstances for this particular problem.”